Cingulate Inc. Gains 268.54%
Fri, Aug 16, 2024 at 07:22 PM
Cingulate Inc. (CING:NASDAQ) rocketted at $17.69, a gain of 268.5%. On Fri, Aug 16, 2024, CING:NASDAQ hit a New 2-Week High of $17.69. The stock appeared on our News Catalysts scanner on Thu, Aug 15, 2024 at 11:02 AM in the 'BIOTECH' category. From Fri, Aug 02, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
About Cingulate Inc. (CING:NASDAQ)
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical...
Top 10 Gainers:
- Cingulate Inc. (CING:NASDAQ), 268.54%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 78.22%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 60.27%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 59.52%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 53.24%
- Inspirato Inc Cl A (ISPO:NASDAQ), 40.69%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 40.63%
- Vroom Inc. (VRM:NASDAQ), 34.83%
- Lumos Pharma, Inc. (LUMO:NASDAQ), 33.47%
- Yoshiharu Global Co. (YOSH:NASDAQ), 32.77%